rs373796693

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1

The NM_000702.4(ATP1A2):​c.13-11_13-8delTCCT variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.805 in 1,573,876 control chromosomes in the GnomAD database, including 516,775 homozygotes. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.73 ( 42415 hom., cov: 0)
Exomes 𝑓: 0.81 ( 474360 hom. )

Consequence

ATP1A2
NM_000702.4 splice_region, intron

Scores

Not classified

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: 1.88

Publications

5 publications found
Variant links:
Genes affected
ATP1A2 (HGNC:800): (ATPase Na+/K+ transporting subunit alpha 2) The protein encoded by this gene belongs to the family of P-type cation transport ATPases, and to the subfamily of Na+/K+ -ATPases. Na+/K+ -ATPase is an integral membrane protein responsible for establishing and maintaining the electrochemical gradients of Na and K ions across the plasma membrane. These gradients are essential for osmoregulation, for sodium-coupled transport of a variety of organic and inorganic molecules, and for electrical excitability of nerve and muscle. This enzyme is composed of two subunits, a large catalytic subunit (alpha) and a smaller glycoprotein subunit (beta). The catalytic subunit of Na+/K+ -ATPase is encoded by multiple genes. This gene encodes an alpha 2 subunit. Mutations in this gene result in familial basilar or hemiplegic migraines, and in a rare syndrome known as alternating hemiplegia of childhood. [provided by RefSeq, Oct 2008]
ATP1A2 Gene-Disease associations (from GenCC):
  • hemiplegic migraine-developmental and epileptic encephalopathy spectrum
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • migraine, familial hemiplegic, 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • alternating hemiplegia of childhood 1
    Inheritance: AD Classification: STRONG, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • developmental and epileptic encephalopathy 98
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)
  • fetal akinesia, respiratory insufficiency, microcephaly, polymicrogyria, and dysmorphic facies
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • alternating hemiplegia of childhood
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • familial or sporadic hemiplegic migraine
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP6
Variant 1-160120891-CCCTT-C is Benign according to our data. Variant chr1-160120891-CCCTT-C is described in ClinVar as [Benign]. Clinvar id is 166705.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.834 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ATP1A2NM_000702.4 linkc.13-11_13-8delTCCT splice_region_variant, intron_variant Intron 1 of 22 ENST00000361216.8 NP_000693.1 P50993A0A0S2Z3W6

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ATP1A2ENST00000361216.8 linkc.13-14_13-11delCCTT intron_variant Intron 1 of 22 1 NM_000702.4 ENSP00000354490.3 P50993
ATP1A2ENST00000392233.7 linkc.13-14_13-11delCCTT intron_variant Intron 1 of 22 5 ENSP00000376066.3 B1AKY9
ATP1A2ENST00000472488.5 linkn.116-14_116-11delCCTT intron_variant Intron 1 of 19 2
ATP1A2ENST00000478587.1 linkn.112-14_112-11delCCTT intron_variant Intron 1 of 1 3

Frequencies

GnomAD3 genomes
AF:
0.726
AC:
110308
AN:
151896
Hom.:
42399
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.450
Gnomad AMI
AF:
0.771
Gnomad AMR
AF:
0.846
Gnomad ASJ
AF:
0.837
Gnomad EAS
AF:
0.844
Gnomad SAS
AF:
0.675
Gnomad FIN
AF:
0.890
Gnomad MID
AF:
0.797
Gnomad NFE
AF:
0.829
Gnomad OTH
AF:
0.761
GnomAD2 exomes
AF:
0.802
AC:
145273
AN:
181048
AF XY:
0.800
show subpopulations
Gnomad AFR exome
AF:
0.443
Gnomad AMR exome
AF:
0.902
Gnomad ASJ exome
AF:
0.841
Gnomad EAS exome
AF:
0.843
Gnomad FIN exome
AF:
0.887
Gnomad NFE exome
AF:
0.823
Gnomad OTH exome
AF:
0.821
GnomAD4 exome
AF:
0.814
AC:
1156790
AN:
1421862
Hom.:
474360
AF XY:
0.811
AC XY:
570564
AN XY:
703848
show subpopulations
African (AFR)
AF:
0.435
AC:
14063
AN:
32312
American (AMR)
AF:
0.897
AC:
34245
AN:
38156
Ashkenazi Jewish (ASJ)
AF:
0.844
AC:
21495
AN:
25482
East Asian (EAS)
AF:
0.804
AC:
29709
AN:
36940
South Asian (SAS)
AF:
0.693
AC:
56382
AN:
81388
European-Finnish (FIN)
AF:
0.888
AC:
44998
AN:
50686
Middle Eastern (MID)
AF:
0.750
AC:
4232
AN:
5644
European-Non Finnish (NFE)
AF:
0.828
AC:
904614
AN:
1092322
Other (OTH)
AF:
0.798
AC:
47052
AN:
58932
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
10028
20056
30084
40112
50140
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20662
41324
61986
82648
103310
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.726
AC:
110354
AN:
152014
Hom.:
42415
Cov.:
0
AF XY:
0.730
AC XY:
54231
AN XY:
74306
show subpopulations
African (AFR)
AF:
0.449
AC:
18628
AN:
41442
American (AMR)
AF:
0.846
AC:
12923
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.837
AC:
2906
AN:
3470
East Asian (EAS)
AF:
0.844
AC:
4355
AN:
5158
South Asian (SAS)
AF:
0.677
AC:
3269
AN:
4832
European-Finnish (FIN)
AF:
0.890
AC:
9412
AN:
10580
Middle Eastern (MID)
AF:
0.793
AC:
233
AN:
294
European-Non Finnish (NFE)
AF:
0.829
AC:
56318
AN:
67946
Other (OTH)
AF:
0.763
AC:
1610
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
1313
2625
3938
5250
6563
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
818
1636
2454
3272
4090
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.781
Hom.:
7935
Bravo
AF:
0.720
Asia WGS
AF:
0.743
AC:
2585
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:11
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
Mar 17, 2014
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 15, 2024
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 98% of patients studied in a panel designed for Epileptic and Developmental Encephalopathy and Progressive Myoclonus Epilepsy. Number of patients: 91. Only high quality variants are reported. -

Jun 13, 2013
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The variant is found in EPILEPSY panel(s). -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Familial hemiplegic migraine Benign:2
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Fetal akinesia, respiratory insufficiency, microcephaly, polymicrogyria, and dysmorphic facies Benign:1
Dec 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Alternating hemiplegia of childhood Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Developmental and epileptic encephalopathy 98 Benign:1
Dec 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Migraine, familial hemiplegic, 2 Benign:1
Dec 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Alternating hemiplegia of childhood 1 Benign:1
Jul 14, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
1.9
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs373796693; hg19: chr1-160090681; API